Patents Assigned to Err-Cheng CHAN
  • Method of PLSCR inhibition for cancer therapy
    Patent number: 8691229
    Abstract: The present invention relates to a method of using inhibitors of phospholipid scramblases (PLSCRs) for the prophylactic or therapeutic treatment of cancers. The PLSCR-inhibitors of the invention comprise compounds PLSCR-specific monoclonal antibodies, antagonists or nucleic acids, which have ability to decrease the level and/or biological activity of PLSCRs in cancer cells.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: April 8, 2014
    Assignee: Err-Cheng CHAN
    Inventors: Err-Cheng Chan, Hong-Arh Fan, Kuei-Tien Chen, Yung-Bin Kuo, Jinn-Shiun Chen, Chung-Wei Fan